Alnylam

Reworking the Broken R&D Model
Motley Fool
Wed, 04/22/09 - 07:15 am
R&D
GSK
Merck
Isis Pharmaceuticals
Alnylam
Bristol-Myers Squibb
Gilead Sciences
Pfizer
Alkermes
Amylin
FDA, Clinical Trial Calendar Updates: Alnylam Announces Phase 1 Trial
Seeking Alpha
Tue, 04/7/09 - 09:27 am
FDA
drug trials
Theravance
Gilead Sciences
Teva Pharmaceuticals
Alnylam
ReNeuron
Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients With Liver Cancer
Fox Business News
Sat, 04/4/09 - 10:56 am
Tekmira Pharmaceuticals
Alnylam
Tekmira Partner Alnylam Receives Clearance From FDA to Initiate Clinical Trial Utilizing SNALP
MSNBC
Sat, 01/24/09 - 12:45 pm
Tekmira Pharmaceuticals
Alnylam
SNALP
Cubist, Alnylam Partner in $102.5M RNAi Drugs Deal
TMCnet
Sat, 01/10/09 - 12:23 pm
Cubist Pharmaceuticals
Alnylam
Alnylam, Cubist to collaborate
Bizjournals.com
Fri, 01/9/09 - 12:22 pm
Alnylam
Cubist Pharmaceuticals
Biotech Clinical Trials to Watch in 2009
TheStreet.com
Thu, 12/18/08 - 03:43 pm
drug trials
Alnylam
Amgen
Amicus Therapeutics
Arena Pharmaceuticals
Biogen Idec
Chelsea Therapeutics
Genentech
Gilead Sciences
Human Genome Sciences
InterMune
Isis Pharmaceuticals
Neurocrine
ONYX Pharmaceuticals
Orexigen
Osiris Therapeutics
Poniard
Rigel
United Therapeutics
Synta
Deal of the Year Nominee: Alnylam/Takeda
InVivo
Wed, 12/17/08 - 05:13 pm
Takeda
Alnylam

Pages